Apexium Financial’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$291K Hold
3,146
0.01% 246
2025
Q2
$251K Hold
3,146
0.01% 244
2025
Q1
$272K Hold
3,146
0.02% 234
2024
Q4
$260K Hold
3,146
0.02% 223
2024
Q3
$274K Sell
3,146
-281
-8% -$24K 0.02% 199
2024
Q2
$282K Sell
3,427
-559
-14% -$44.4K 0.02% 186
2024
Q1
$320K Sell
3,986
-1,017
-20% -$78.8K 0.02% 173
2023
Q4
$381K Sell
5,003
-144
-3% -$10.3K 0.03% 194
2023
Q3
$372K Sell
5,147
-332
-6% -$25.5K 0.04% 153
2023
Q2
$414K Sell
5,479
-1,136
-17% -$86.7K 0.04% 150
2023
Q1
$503K Hold
6,615
0.05% 130
2022
Q4
$520K Hold
6,615
0.05% 130
2022
Q3
$472K Buy
+6,615
New +$493K 0.06% 125

Other funds holding PJP

Apexium Financial's PJP Position: Q3 2025 in Review

Apexium Financial held its Invesco Pharmaceuticals ETF (PJP) position steady in Q3 2025 at 3,146 shares worth $291K. The position accounts for 0.01% of the portfolio, ranked #246.

Apexium Financial first reported a position in PJP in Q3 2022 and has held it in 13 quarters since. The position peaked at $520K in Q4 2022. 93 funds tracked by Wall St. Rank hold PJP as of Q3 2025.

  • Apexium Financial held 3,146 shares of Invesco Pharmaceuticals ETF worth $291K as of Q3 2025.
  • Apexium Financial left its Invesco Pharmaceuticals ETF share count unchanged in Q3 2025.
  • Invesco Pharmaceuticals ETF made up 0.01% of Apexium Financial's portfolio in Q3 2025, its #246 holding.
  • Apexium Financial first reported a position in Invesco Pharmaceuticals ETF in Q3 2022 and has held it in 13 quarters since.
  • Apexium Financial's Invesco Pharmaceuticals ETF position peaked at $520K in Q4 2022.
  • 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2025.

Based on Apexium Financial's 13F filing for Q3 2025, filed 18 Nov 2025.